Clinical manifestations and diagnosis of HIV-2 infection
- Geoffrey S Gottlieb, MD, PhD
Geoffrey S Gottlieb, MD, PhD
- Professor of Medicine/Infectious Diseases
- Adjunct Professor of Global Health
- University of Washington School of Medicine
Although HIV-1 infection is associated with most of the global AIDS pandemic, HIV-2 is an important cause of disease in West Africa, where it is endemic. HIV-2 infection has also been described in locales with cultural and socioeconomic ties to West Africa, including the United States. It is an important consideration in patients with an AIDS-like illness or among persons with epidemiologic risk factors for infection . Epidemiologic risk factors are similar to HIV-1 infection and include a past history of blood transfusion or having a sex partner or needle-sharing partner with HIV-2 infection.
This topic will address the clinical manifestations and diagnosis of HIV-2 infection. The epidemiology, transmission, natural history, pathogenesis and treatment of HIV-2 are discussed elsewhere. (See "Epidemiology, transmission, natural history, and pathogenesis of HIV-2 infection" and "Treatment of HIV-2 infection".)
STAGING OF DISEASE
In HIV-1 infected patients, two important laboratory determinants of the rate of progression are the CD4 cell count and the plasma viral load [2,3]. In untreated patients, the average rate of decline of CD4 cells ("CD4 slope") is about 50/mm3 per year and the average plasma RNA viral load (without therapy) is 30,000 to 50,000 copies/mL [2-4]. Patients with a CD4 cell count <200 cells/mm3 are considered to have AIDS; such patients are at significantly increased risk for opportunistic infections and AIDS-related malignancies. (See "Factors affecting HIV progression".)
There are far fewer data on the CD4 threshold that is associated with an increased risk of AIDS and opportunistic infections among HIV-2 infected patients. Most experts apply the same CD4 cell count threshold (<200 cells/mm3) as a laboratory parameter indicating AIDS in HIV-2 infected patients.
Laboratory monitoring for HIV-2 RNA viral load is problematic since testing availability in limited. Most commercial laboratories do not offer testing for HIV-2 RNA viral load and the few that do offer only qualitative testing (eg, Focus and Quest Diagnostics laboratories). Quantitative HIV-2 RNA viral load testing may be obtained from the following few laboratories [5-8]:
- Campbell-Yesufu OT, Gandhi RT. Update on human immunodeficiency virus (HIV)-2 infection. Clin Infect Dis 2011; 52:780.
- Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167.
- Mellors JW, Muñoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946.
- Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279:35.
- Damond F, Benard A, Ruelle J, et al. Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J Clin Microbiol 2008; 46:2088.
- Damond F, Benard A, Balotta C, et al. An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study. J Clin Microbiol 2011; 49:3491.
- Chang M, Gottlieb GS, Dragavon JA, et al. Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol 2012; 55:128.
- Styer LM, Miller TT, Parker MM. Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control. J Clin Virol 2013; 58 Suppl 1:e127.
- Prazuck T, Yameogo JM, Heylinck B, et al. Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso. Pediatr Infect Dis J 1995; 14:940.
- Gottlieb GS, Hawes SE, Agne HD, et al. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS 2006; 20:895.
- Burgard M, Jasseron C, Matheron S, et al. Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. Clin Infect Dis 2010; 51:833.
- Hawes SE, Sow PS, Stern JE, et al. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS 2008; 22:2517.
- Simon F, Matheron S, Tamalet C, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993; 7:1411.
- Christiansen CB, Jessen TE, Nielsen C, Staun-Olsen P. False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection. Vox Sang 1996; 70:144.
- Besnier JM, Barin F, Baillou A, et al. Symptomatic HIV-2 primary infection. Lancet 1990; 335:798.
- Kanki PJ, Travers KU, MBoup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943.
- Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 transmission in the French prospective cohort. The HIV Infection in Newborns French Collaborative Study Group. Pediatr Infect Dis J 1994; 13:502.
- Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462.
- Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587.
- Gottlieb GS, Sow PS, Hawes SE, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002; 185:905.
- Gilbert PB, McKeague IW, Eisen G, et al. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med 2003; 22:573.
- MacNeil A, Sarr AD, Sankalé JL, et al. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol 2007; 81:5325.
- Popper SJ, Sarr AD, Travers KU, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999; 180:1116.
- Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997; 349:911.
- Martinez-Steele E, Awasana AA, Corrah T, et al. Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS 2007; 21:317.
- 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1.
- Ndour M, Sow PS, Coll-Seck AM, et al. AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986-97 at Fann Hospital in Dakar, Senegal. Trop Med Int Health 2000; 5:687.
- De Cock KM, Odehouri K, Colebunders RL, et al. A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Côte d'Ivoire. AIDS 1990; 4:443.
- Matheron S, Mendoza-Sassi G, Simon F, et al. HIV-1 and HIV-2 AIDS in African patients living in Paris. AIDS 1997; 11:934.
- Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993; 7:1569.
- Ariyoshi K, Schim van der Loeff M, Cook P, et al. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1:193.
- Hawes SE, Critchlow CW, Faye Niang MA, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003; 188:555.
- http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM080466 (Accessed on February 22, 2016).
- http://etd.paml.com/etd/display.php?id=7859 (Accessed on February 22, 2016).
- http://www.questdiagnostics.com/testcenter/TestDetail.action?ntc=34977 (Accessed on February 22, 2016).
- http://www.focusdx.com/focus/1-reference_laboratory/search_frame.asp?TestType=&Keyword=hiv-2&Submit2=Go&S1=ON&S2=ON&searchCategory=999&searchOptionScope=1 (Accessed on February 22, 2016).
- http://www.alere.com/en/home/product-details/alere-q-hiv-12-detect.html (Accessed on February 22, 2016).
- http://www.croiconference.org/sessions/poc-alere-q-hiv-12-detect-test-detection-and-quantification-hiv-2 (Accessed on February 22, 2016).
- http://www.cdc.gov/hiv/resources/factsheets/hiv2.htm (Accessed on March 01, 2011).
- O'Brien TR, George JR, Epstein JS, et al. Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR Recomm Rep 1992; 41:1.
- Centers for Disease Control and Prevention (CDC). HIV-2 Infection Surveillance--United States, 1987-2009. MMWR Morb Mortal Wkly Rep 2011; 60:985.
- Centers for Disease Control and Prevention (CDC). Laboratory Testing for the Diagnosis of HIV Infection:Updated Recommendations. http://www.cdc.gov/hiv/pdf/hivtestingalgorithmrecommendation-final.pdf (Accessed on July 07, 2014).
- Gottlieb GS, Smith RA, Sow PS. Long-term nonprogressive disease among individuals with untreated HIV infection. JAMA 2010; 304:1784; author reply 1785.
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf (Accessed on January 28, 2016).
- STAGING OF DISEASE
- RISK FACTORS FOR CLINICAL PROGRESSION
- CLINICAL MANIFESTATIONS
- Primary HIV-2 infection
- Chronic infection
- TESTING FOR HIV-2 INFECTION
- Which tests to order?
- DIAGNOSTIC ISSUES RELATED TO HIV-1 WESTERN BLOT TESTING
- General background
- Interpretation of Western blot test results
- - A reactive HIV-1 Western blot
- - An indeterminate HIV-1 Western blot
- - A negative HIV-1 Western blot
- WHEN TO SUSPECT HIV-2 INFECTION
- Clinical clues to possible HIV-2 infection
- Laboratory clues for possible HIV-2 infection
- WHO SHOULD BE SCREENED?
- SOCIETY GUIDELINE LINKS
- SUMMARY AND RECOMMENDATIONS